2018 Honda Civic Sport Touring Hatchback 4d on 2040-cars

Auto blog

Honda accused of not reporting all airbag problems

The Takata airbag recall that has afflicted a number of automakers may have just taken a very bad turn for Honda, which has already recalled over one million vehicles. Clarence Ditlow and the Center for Auto Safety have accused the Japanese manufacturer of failing to report two "injury-and-death" incidents. To determine just what happened, the company has initiated a third-party audit.
According to Bloomberg, CAS claims Honda failed to report fatalities in 2009 and 2013, a point Honda doesn't seem to contest, indicating that it didn't report so-called "verbal claims."
"It is our understanding that some manufacturers choose to include these types of verbal claims, and that these constitute the majority of the injury-and-death claims that they report to the National Highway Traffic Safety Administration," the company told Bloomberg via email. "We believe this practice accounts for the vast majority of the difference between the total number of injury-and-death claims reported by Honda compared to certain other manufacturers."

Honda Walking Assist Device begins US testing at Rehabilitation Institute of Chicago

For years, we've been wondering what implications Honda's Asimo robot could have in the real world, and now we're starting to get a sense of that. Honda announced that it will begin its first US clinical studies of the Walking Assist Device at the Rehabilitation Institute of Chicago in an effort to provided improved mobility for people who have suffered a stroke. While the automotive tie-in here is pretty weak, this is the first time we've heard about this device since it was unveiled back in 2008.
Weighing in at six pounds, Honda's device is fitted to the waist and legs of patients to make it easier to walk, and the 22.2-volt lithium-ion battery provides enough electricity for more than an hour of operation. According to Honda's press release, which is posted below, up to 80 percent of the almost 800,000 stroke victims each year (in the US alone) are afflicted with limited mobility, so a medical aid like this could have a big impact in the real world.

2014 Honda Accord V6 Touring

America's midsize sedan segment is one of the most crowded and fiercely competitive in the business. The Toyota Camry has long been our nation's best seller, while the Honda Accord has dutifully come in second place, like some sort of codependent Cal Naughton Jr. riding Ricky Bobby's back bumper.
There was that one year, 2001, when the Accord briefly broke the Camry's streak, marring what would today have been a 17-year-long run of best-selling car titles. The Accord pulled the opposite move in 2011, letting sales slip far enough to let not only the Toyota by, but the Nissan Altima and Ford Fusion, as well. Aside from those anomalies, the Camry and Accord have been first and second in this segment since before many of you readers could even drive.
It's 2014, and these frenemies have never before faced a threat to their world order as strong as today's class of family sedans. The aforementioned Altima and Fusion are perhaps the most capable challengers, but the Chevrolet Malibu, Hyundai Sonata, Kia Optima, Volkswagen Passat and Mazda6 are all capable of convincing new buyers to walk their way.